These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 10795957

  • 1. Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study.
    Cornelius JR, Salloum IM, Haskett RF, Daley DC, Cornelius MD, Thase ME, Perel JM.
    Addict Behav; 2000; 25(2):307-10. PubMed ID: 10795957
    [Abstract] [Full Text] [Related]

  • 2. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR, Salloum IM, Thase ME, Haskett RF, Daley DC, Jones-Barlock A, Upsher C, Perel JM.
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [Abstract] [Full Text] [Related]

  • 3. Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.
    Cornelius JR, Bukstein OG, Douaihy AB, Clark DB, Chung TA, Daley DC, Wood DS, Brown SJ.
    Drug Alcohol Depend; 2010 Nov 01; 112(1-2):39-45. PubMed ID: 20576364
    [Abstract] [Full Text] [Related]

  • 4. Fluoxetine versus placebo for the marijuana use of depressed alcoholics.
    Cornelius JR, Salloum IM, Haskett RF, Ehler JG, Jarrett PJ, Thase ME, Perel JM.
    Addict Behav; 1999 Nov 01; 24(1):111-4. PubMed ID: 10189977
    [Abstract] [Full Text] [Related]

  • 5. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB, Farabaugh A, Johnson MW, Morray M, Delgado ML, Pingol MG, Rosenbaum JF, Fava M.
    J Psychopharmacol; 2002 Sep 01; 16(3):215-9. PubMed ID: 12236627
    [Abstract] [Full Text] [Related]

  • 6. Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial.
    Cornelius JR, Salloum IM, Ehler JG, Jarrett PJ, Cornelius MD, Perel JM, Thase ME, Black A.
    Arch Gen Psychiatry; 1997 Aug 01; 54(8):700-5. PubMed ID: 9283504
    [Abstract] [Full Text] [Related]

  • 7. Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression.
    Abolfazli R, Hosseini M, Ghanizadeh A, Ghaleiha A, Tabrizi M, Raznahan M, Golalizadeh M, Akhondzadeh S.
    Depress Anxiety; 2011 Apr 01; 28(4):297-302. PubMed ID: 21456039
    [Abstract] [Full Text] [Related]

  • 8. Preliminary report: double-blind, placebo-controlled study of fluoxetine in depressed alcoholics.
    Cornelius JR, Salloum IM, Cornelius MD, Perel JM, Ehler JG, Jarrett PJ, Levin RL, Black A, Mann JJ.
    Psychopharmacol Bull; 1995 Apr 01; 31(2):297-303. PubMed ID: 7491382
    [Abstract] [Full Text] [Related]

  • 9. Double-blind fluoxetine in depressed alcoholic smokers.
    Cornelius JR, Salloum IM, Ehler JG, Jarrett PJ, Cornelius MD, Black A, Perel JM, Thase ME.
    Psychopharmacol Bull; 1997 Apr 01; 33(1):165-70. PubMed ID: 9133770
    [Abstract] [Full Text] [Related]

  • 10. Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse.
    Iovieno N, van Nieuwenhuizen A, Clain A, Baer L, Nierenberg AA.
    Depress Anxiety; 2011 Feb 01; 28(2):137-44. PubMed ID: 21284066
    [Abstract] [Full Text] [Related]

  • 11. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U.
    J Neurol; 2003 Mar 01; 250(3):347-51. PubMed ID: 12638027
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P, Baker B, Irvine J, Dorian P, McKessok D, Mendlowitz S.
    Depress Anxiety; 1998 Mar 01; 7(2):69-72. PubMed ID: 9614594
    [Abstract] [Full Text] [Related]

  • 13. Fluoxetine in depressed AUD adolescents: a 1-year follow-up evaluation.
    Cornelius JR, Bukstein OG, Salloum IM, Kelly TM, Wood DS, Clark DB.
    J Child Adolesc Psychopharmacol; 2004 Mar 01; 14(1):33-8. PubMed ID: 15142389
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.
    Amsterdam JD, Garcia-España F, Fawcett J, Quitkin FM, Reimherr FW, Rosenbaum JF, Schweizer E, Beasley C.
    J Clin Psychopharmacol; 1998 Dec 01; 18(6):435-40. PubMed ID: 9864074
    [Abstract] [Full Text] [Related]

  • 15. A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.
    Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Murck H, Rosenbaum JF.
    J Clin Psychopharmacol; 2005 Oct 01; 25(5):441-7. PubMed ID: 16160619
    [Abstract] [Full Text] [Related]

  • 16. An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
    Trivedi MH, Thase ME, Osuntokun O, Henley DB, Case M, Watson SB, Campbell GM, Corya SA.
    J Clin Psychiatry; 2009 Mar 01; 70(3):387-96. PubMed ID: 19284928
    [Abstract] [Full Text] [Related]

  • 17. Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: a review.
    Cornelius JR, Clark DB, Bukstein OG, Birmaher B, Salloum IM, Brown SA.
    Addict Behav; 2005 Oct 01; 30(9):1824-33. PubMed ID: 16102905
    [Abstract] [Full Text] [Related]

  • 18. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
    Gillin JC, Rapaport M, Erman MK, Winokur A, Albala BJ.
    J Clin Psychiatry; 1997 May 01; 58(5):185-92. PubMed ID: 9184611
    [Abstract] [Full Text] [Related]

  • 19. Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics.
    Kranzler HR, Burleson JA, Korner P, Del Boca FK, Bohn MJ, Brown J, Liebowitz N.
    Am J Psychiatry; 1995 Mar 01; 152(3):391-7. PubMed ID: 7864265
    [Abstract] [Full Text] [Related]

  • 20. Psychosocial functioning during the treatment of major depressive disorder with fluoxetine.
    Papakostas GI, Petersen T, Denninger JW, Tossani E, Pava JA, Alpert JE, Nierenberg AA, Fava M.
    J Clin Psychopharmacol; 2004 Oct 01; 24(5):507-11. PubMed ID: 15349006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.